Many Americans don't see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks ...

Adjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer ...

Health guidelines now advise against the practice for most people, because it increases likelihood of brain and ...

In one trial, 635 patients with previously resected colorectal cancer received daily aspirin (325 mg) or placebo. During an average follow-up of 31 months (during which most patients underwent 1 ...

Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for predicting radiotherapy benefit in DCIS, and nivolumab plus chemotherapy ...

All patients were ... Study Finds Regular Aspirin Use Associated With Greatest Reduction in Colorectal Cancer Among Those Most at Risk Aug. 1, 2024 — In a study of more than 100,000 people ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance of upfront genomic testing. Adults with primary primary appendiceal ...

"I am not anti-vaccine." -- Robert F. Kennedy Jr., President Donald Trump's nominee for HHS secretary, attempting to allay Senators' concerns about his anti-vaccine advocacy during a confirmation ...

If you're over the age of 60, you've likely seen headlines in the last couple of years warning against previous medical advice to take aspirin as a preventative measure against heart attack and ...